It is postulated that the downregulation of BATF3 may impair dendritic cells function, thereby affecting γδ T cells and resulting in aberrant γδ T cell infiltration in NASH and CAD. The gene discussed is BATF3; the disease is metabolic dysfunction-associated steatohepatitis.